(Reuters) -Zimmer Biomet Holdings on Monday lowered its full-year adjusted profit forecast, as the medical device maker anticipates a hit from its recent acquisition of Paragon 28, currency volatility, and proposed tariffs. Investors and analysts are closely monitoring how medical device makers will handle …
Integra LifeSciences (IART) came out with quarterly earnings of $0.41 per share, missing the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.55 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …
Zimmer Biomet (ZBH) came out with quarterly earnings of $1.81 per share, beating the Zacks Consensus Estimate of $1.76 per share. This compares to earnings of $1.94 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …
Park Hotels & Resorts (PK) came out with quarterly funds from operations (FFO) of $0.46 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to FFO of $0.52 per share a year ago. These figures are adjusted for non-recurring items. …
The United States market has shown positive momentum, with a 2.8% increase over the last week and a 9.3% rise in the past year, while earnings are anticipated to grow by 14% annually in the coming years. In this environment, identifying stocks that may …
The United States market has shown a positive trend, with a 2.8% increase over the last week and a 9.3% rise over the past year, while earnings are projected to grow by 14% annually in the coming years. In this environment, identifying high growth …
The United States market has experienced a positive trend, rising 2.8% over the last week and 9.3% over the past year, with earnings expected to grow by 14% annually. In this environment, identifying growth companies with high insider ownership can be particularly appealing as …
Recent advancements in the biotechnology sector highlight a significant development with RetinalGenix Technologies, Inc. leasing a laboratory at the MBC BioLabs incubator in San Carlos, California. This strategic move is set to support the progress of RetinalGenix's innovative Pharmaco-Genetic Mapping platform, aimed at advancing …
Key Points Wall Street analysts are bullish on Broadcom and ServiceNow due to their potential in the AI market. Broadcom is benefiting enormously from increasing investment in AI infrastructure. ServiceNow is seeing high demand for its business automation software. In a year of uncertainty …
HAZER GROUP LIMITED Highlights BindingstrategicalliancewithKBR(NYSE:KBR),aworld-leadingengineeringgroupandglobaltechnology licensor set to supercharge Hazer’s commercialisation strategy HazerisKBR’sexclusivepartnerformarketingandlicensingofmethanepyrolysistechnology Clearrevenuevisibilitytargetingmultiplelicensedealswithin6years,materiallyderiskingHazer’sbusiness plan Capital-litelicensingmodelmaintained;KBRA$3millionworkprogramcontributionpreservesHazer’s robust funding position StrengthensHazer’smarketpenetrationintohigh-growthmarketsegmentsofammoniaandmethanol, and regions including North America and Middle East CEOGlennCorrieandothermembersofthemanagementteamwillbehostingawebinaronWednesday, 07 May 2025 at 09:00am (AWST) / 11:00am (AEST). Details provided below PERTH, Australia, May …